Vivo Opportunity, LLC insider trades: InMed Pharmaceuticals (INM) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Vivo Opportunity, LLC reports to the SEC
and 2 more companies
Open-market buys and sales
42 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 16, 2026 | INM | ↑ Buy | 18,662 | $1.55 | $29K | By Vivo Opportunity Fund Holdings, L.P. | Jul 16, 2026 (0d) |
| Jul 16, 2026 | INM | ↑ Buy | 1,884 | $1.55 | $3K | By Vivo Opportunity Cayman Fund, L.P. | Jul 16, 2026 (0d) |
| Jul 2, 2026 | INM | ↑ Buy | 5,951 | $1.55 | $9K | By Vivo Opportunity Fund Holdings, L.P. | Jul 2, 2026 (0d) |
| Jul 2, 2026 | INM | ↑ Buy | 600 | $1.55 | $929 | By Vivo Opportunity Cayman Fund, L.P. | Jul 2, 2026 (0d) |
| Jun 8, 2026 | INM | ↑ Buy | 226,371 | $1.57 | $356K | By Vivo Opportunity Fund Holdings, L.P. | Jun 10, 2026 (2d) |
| Jun 8, 2026 | INM | ↑ Buy | 22,856 | $1.57 | $36K | By Vivo Opportunity Cayman Fund, L.P. | Jun 10, 2026 (2d) |
| Mar 28, 2025 | SLNO | ↓ Sell | 1,833,557 | $67.87 | $124.4M | By Vivo Opportunity Fund Holdings, L.P. | Mar 28, 2025 (0d) |
| Aug 29, 2024 | SLNO | ↓ Sell | 1,025,000 | $48.01 | $49.2M | By Vivo Opportunity Fund Holdings, L.P. | Aug 29, 2024 (0d) |
| Apr 30, 2024 | SLNO | ↓ Sell | 1,101,242 | $46.95 | $51.7M | By Vivo Opportunity Fund Holdings, L.P. | May 1, 2024 (1d) |
| Apr 3, 2024 | TERN | ↓ Sell | 316,471 | $6.65 | $2.1M | By Vivo Opportunity Fund Holdings, L.P. | Apr 3, 2024 (0d) |
| Apr 3, 2024 | TERN | ↓ Sell | 91,542 | $6.65 | $609K | By: Vivo Capital Fund VIII, L.P. | Apr 3, 2024 (0d) |
| Apr 3, 2024 | TERN | ↓ Sell | 12,650 | $6.65 | $84K | By: Vivo Capital Surplus Fund VIII, L.P. | Apr 3, 2024 (0d) |
| Nov 21, 2023 | BOLT | ↓ Sell | 1,707 | $0.90 | $2K | By: Vivo Capital Fund VIII, L.P. | Nov 22, 2023 (1d) |
| Nov 21, 2023 | BOLT | ↓ Sell | 1,457 | $0.90 | $1K | By: Vivo Opportunity Fund Holdings, L.P. | Nov 22, 2023 (1d) |
| Nov 21, 2023 | BOLT | ↓ Sell | 236 | $0.90 | $212 | By: Vivo Capital Surplus Fund VIII, L.P. | Nov 22, 2023 (1d) |
| Nov 20, 2023 | BOLT | ↓ Sell | 36,881 | $0.93 | $34K | By: Vivo Opportunity Fund Holdings, L.P. | Nov 20, 2023 (0d) |
| Nov 20, 2023 | BOLT | ↓ Sell | 27,465 | $0.92 | $25K | Vivo Capital Fund VIII, L.P. | Nov 20, 2023 (0d) |
| Nov 20, 2023 | BOLT | ↓ Sell | 5,966 | $0.93 | $6K | By: Vivo Capital Surplus Fund VIII, L.P. | Nov 20, 2023 (0d) |
| Nov 17, 2023 | BOLT | ↓ Sell | 8,211 | $0.93 | $8K | By: Vivo Capital Fund VIII, L.P. | Nov 20, 2023 (3d) |
| Nov 16, 2023 | BOLT | ↓ Sell | 7,531 | $0.96 | $7K | By: Vivo Capital Fund VIII, L.P. | Nov 20, 2023 (4d) |
| Aug 9, 2023 | IOBT | ↑ Buy | 3,157,894 | $1.90 | $6.0M | By Vivo Opportunity Fund Holdings, L.P. | Aug 10, 2023 (1d) |
| Dec 23, 2022 | TERN | ↑ Buy | 758,620 | $7.25 | $5.5M | By Vivo Opportunity Fund Holdings, L.P. | Dec 23, 2022 (0d) |
| Sep 7, 2022 | TERN | ↑ Buy | 600,000 | $3.60 | $2.2M | By Vivo Opportunity Fund Holdings, L.P. | Sep 8, 2022 (1d) |
| Aug 16, 2022 | TERN | ↑ Buy | 1,501,218 | $2.42 | $3.6M | By: Vivo Opportunity Fund Holdings, L.P. | Aug 16, 2022 (0d) |
| Aug 12, 2022 | TERN | ↑ Buy | 1,123,021 | $2.98 | $3.3M | By Vivo Opportunity Fund Holdings, L.P. | Aug 16, 2022 (4d) |
| Jan 31, 2022 | SRRA | ↑ Buy | 800,000 | $27.00 | $21.6M | By Vivo Opportunity Fund, L.P. | Jan 31, 2022 (0d) |
| Feb 9, 2021 | TERN | ↑ Buy | 357,353 | $17.00 | $6.1M | Vivo Opportunity Fund, L.P. | Feb 9, 2021 (0d) |
| Feb 9, 2021 | BOLT | ↑ Buy | 175,733 | $20.00 | $3.5M | By Vivo Capital Fund VIII, L.P. | Feb 9, 2021 (0d) |
| Feb 9, 2021 | BOLT | ↑ Buy | 150,000 | $20.00 | $3.0M | By Vivo Opportunity Fund, L.P. | Feb 9, 2021 (0d) |
| Feb 9, 2021 | TERN | ↑ Buy | 103,372 | $17.00 | $1.8M | Vivo Capital Fund VIII, L.P. | Feb 9, 2021 (0d) |
| Feb 9, 2021 | BOLT | ↑ Buy | 24,267 | $20.00 | $485K | By Vivo Capital Surplus Fund VIII, L.P. | Feb 9, 2021 (0d) |
| Feb 9, 2021 | TERN | ↑ Buy | 14,275 | $17.00 | $243K | Vivo Capital Surplus Fund VIII, L.P. | Feb 9, 2021 (0d) |
| Feb 9, 2021 | BOLT | ↓ Sell | 144 | $20.00 | $3K | By Vivo Capital Fund VIII, L.P. | Feb 9, 2021 (0d) |
| Feb 9, 2021 | BOLT | ↓ Sell | 62 | $20.00 | $1K | By Vivo PANDA Fund, L.P. | Feb 9, 2021 (0d) |
| Feb 9, 2021 | BOLT | ↓ Sell | 20 | $20.00 | $400 | By Vivo Capital Surplus Fund VIII, L.P. | Feb 9, 2021 (0d) |
| Jul 21, 2020 | ALXO | ↑ Buy | 975,000 | $19.00 | $18.5M | Indirect | Jul 21, 2020 (0d) |
| Mar 9, 2020 | CRNX | ↓ Sell | 528 | $19.50 | $10K | Indirect | Mar 11, 2020 (2d) |
| Feb 10, 2020 | CRNX | ↓ Sell | 13,460 | $21.66 | $292K | See foonotes | Feb 11, 2020 (1d) |
| Feb 4, 2020 | CRNX | ↓ Sell | 13,460 | $22.80 | $307K | Indirect | Feb 6, 2020 (2d) |
| Jan 31, 2020 | CRNX | ↓ Sell | 26,920 | $22.07 | $594K | See foonotes | Jan 31, 2020 (0d) |
| Mar 20, 2019 | CRNX | ↓ Sell | 417,000 | $22.25 | $9.3M | Indirect | Mar 25, 2019 (5d) |
| Jul 20, 2018 | CRNX | ↑ Buy | 353,180 | $18.62 | $6.6M | Indirect | Jul 20, 2018 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other INM insiders
Open-market trades in the last 12 months
About Vivo Opportunity, LLC's insider trades
Vivo Opportunity, LLC is a 10% owner of InMed Pharmaceuticals (INM). Since Jul 20, 2018, it has reported 20 open-market purchases worth $82.8M and 22 sales worth $238.7M on SEC Form 4. In the last 12 months: 6 buys ($434K).
Its filings also include conversions (5 filings), option exercises (4 filings), other transactions (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every INM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.